Mechanotransduction governs CD40 function and underlies X-linked hyper-IgM syndrome

被引:0
|
作者
Choi, Hyun-Kyu [1 ,2 ,3 ,4 ]
Travaglino, Stefano [1 ,2 ,3 ]
Muenchhalfen, Matthias [5 ]
Goerg, Richard [5 ]
Zhong, Zhe [1 ,2 ,6 ]
Lyu, Jintian [1 ,2 ]
Reyes-Aguilar, David M. [1 ,2 ]
Wienands, Juergen [5 ]
Singh, Ankur [1 ,2 ,3 ,6 ]
Zhu, Cheng [1 ,2 ,3 ,6 ]
机构
[1] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA
[2] Emory Univ, Atlanta, GA 30332 USA
[3] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA
[4] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea
[5] Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, D-13 Gottingen, Germany
[6] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA
来源
SCIENCE ADVANCES | 2024年 / 10卷 / 46期
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
B-CELL RESPONSES; CD40-INDUCED GENE-EXPRESSION; CLASS SWITCH RECOMBINATION; ACTIVATED PROTEIN-KINASE; LIGAND BINDING-KINETICS; GERMINAL-CENTER; CATCH BONDS; RECEPTOR; ADHESION; INTEGRIN;
D O I
10.1126/sciadv.adl5815
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
B cell maturation depends on cognate interactions between the T and B cells. Upon interaction with CD40 ligand (CD40L) on T cells, CD40 delivers costimulatory signals alongside B cell antigen receptor (BCR) signaling to regulate affinity maturation and antibody class switch. Mutations affecting CD40-CD40L interactions cause abnormal antibody responses in immunodeficiencies known as X-linked hyper-IgM syndrome (X-HIgM). Here, we study the CD40-mediated mechanotransduction in B cells, which likely occurs during their physical contacts with T cells. We found that CD40 forms catch bond with CD40L that lasts longer at larger forces, both B and T cells exert tension on CD40-CD40L bonds, and force enhances CD40 signaling and antibody class switch. X-HIgM CD40L mutations impair catch bond formation, suppress endogenous tension, and reduce force-enhanced CD40 signaling, leading to deficiencies in antibody class switch. Our findings highlight the role of mechanotransduction in CD40 function and provide insights into the mechanisms underlying X-HIgM syndrome.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability
    Lobo, FM
    Scholl, PR
    Fuleihan, KL
    JOURNAL OF IMMUNOLOGY, 2002, 168 (03): : 1473 - 1478
  • [42] Novel CD40 Genetic Variants in an Infant with Hyper-IgM Syndrome and Parental CD40 analysis
    Majid, Sultan
    Bonagura, Vincent
    Kimura, Nikki
    CLINICAL IMMUNOLOGY, 2024, 262
  • [43] Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome
    Tsuge, I
    Matsuoka, H
    Nakagawa, A
    Kamachi, Y
    Aso, K
    Negoro, T
    Ito, M
    Torii, S
    Watanabe, K
    EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (09) : 735 - 737
  • [44] Targeted Gene Therapy in the Treatment of X-Linked Hyper-IGM Syndrome
    Kuo, C. Y.
    Hoban, M. D.
    Joglekar, A. V.
    Kohn, D. B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S182 - S182
  • [45] Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome
    I. Tsuge
    H. Matsuoka
    A. Nakagawa
    Y. Kamachi
    K. Aso
    T. Negoro
    M. Ito
    S. Torii
    K. Watanabe
    European Journal of Pediatrics, 1998, 157 : 735 - 737
  • [46] Clinical and genetic analysis of patients with X-linked hyper-IgM syndrome
    Vargas-Hernandez, A.
    Berron-Ruiz, L.
    Staines-Boone, T.
    Zarate-Hernandez, MdC
    Cordova-Calderon, W. O.
    Espinosa-Rosales, F. J.
    Santos-Argumedo, L.
    CLINICAL GENETICS, 2013, 83 (06) : 585 - 587
  • [47] Visceral Leishmaniasis May Unmask X-linked Hyper-IgM Syndrome
    Luis Ignacio Gonzalez-Granado
    Nerea Dominguez-Pinilla
    Fernando Gallego-Bustos
    Jesús Ruiz-Contreras
    Luis M. Allende
    Journal of Clinical Immunology, 2016, 36 : 363 - 365
  • [48] TARGETED GENE THERAPY IN THE TREATMENT OF X-LINKED HYPER-IgM SYNDROME
    Kuo, Caroline Y.
    Hoban, Megan D.
    Joglekar, Alok V.
    Kohn, Donald B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (03) : 322 - 323
  • [49] Targeted Gene Therapy in the Treatment of X-Linked Hyper-IgM Syndrome
    Kuo, Caroline Y.
    Hoban, Megan D.
    Joglekar, Alok V.
    Kohn, Donald B.
    MOLECULAR THERAPY, 2014, 22 : S36 - S36
  • [50] Targeted Gene Therapy in the Treatment of X-Linked Hyper-Igm Syndrome
    Kuo, Caroline Y.
    Joglekar, Alok V.
    Kohn, Donald B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 362 - 362